Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19 (2021)

Peer-Reviewed Study · Temple C, Hoang R, Hendrickson RG (Oregon Health and Science University) · December 2, 2021

Temple C et al., 2021-12-02: Oregon Poison Center series of 21 people who took ivermectin for Covid-19 in August 2021: 6 were hospitalised, 4 in ICU, with confusion, ataxia, weakness, hypotension and one seizure; none died.

Reported doses ingested by the persons who had been using veterinary products ranged from 6.8 mg to 125 mg of 1.87% paste and 20 to 50 mg of the 1% solution.

Temple C et al., 2021-12-02: Oregon Poison Center series of 21 people who took ivermectin for Covid-19 in August 2021: 6 were hospitalised, 4 in ICU, with confusion, ataxia, weakness, hypotension and one seizure; none died. C9 toxicity. Study type: poison-centre case series (correspondence). Country: USA (Oregon, Alaska, Guam catchment). N=21 calls in August 2021; 17 had bought veterinary formulations, 3 had prescriptions. Doses: 6.8-125 mg of 1.87% paste, 20-50 mg of 1% solution, or 21 mg twice weekly for prevention. Symptoms: GI distress (4), confusion (3), ataxia and weakness (2), hypotension (2), seizure (1); 6 hospitalised, 4 ICU, 0 deaths. Funder/conflicts: not stated in the correspondence. This is the record behind the 'horse paste' episodes and the FDA warnings (see C11). Also filed as IVF-26 (claims C4, C9). Study type: uncontrolled series.